Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study

Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae

Clin Mol Hepatol. 2017;23(1):51-56. Published online March 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0053

View: 7923 Download: 211 Web of Science: 12 Crossref: 14

Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)

Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn

Clin Mol Hepatol. 2016;22(4):443-449. Published online November 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0037

View: 9792 Download: 158 Web of Science: 10 Crossref: 8

Editorial

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

Byung-Cheol Song

Clin Mol Hepatol. 2016;22(4):439-442. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0108

View: 7504 Download: 111 Web of Science: 1 Crossref: 1

Review

Management of direct antiviral agent failures

María Buti, Rafael Esteban

Clin Mol Hepatol. 2016;22(4):432-438. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0107

View: 11099 Download: 364 Web of Science: 29 Crossref: 27

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol. 2016;22(4):423-431. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0069

View: 12899 Download: 545 Web of Science: 48 Crossref: 47

Case Report

A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy

Sung Bok Ji, Sang Soo Lee, Hee cheul Jung, Hong Jun Kim, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee, Dae Hyun Song

Clin Mol Hepatol. 2016;22(3):396-399. Published online August 30, 2016

DOI: https://doi.org/10.3350/cmh.2015.0039

View: 16961 Download: 117 Web of Science: 6 Crossref: 8

Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy

Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song

Clin Mol Hepatol. 2016;22(3):390-395. Published online August 30, 2016

DOI: https://doi.org/10.3350/cmh.2015.0050

View: 10493 Download: 132 Web of Science: 1 Crossref: 2

Original Article

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B

Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clin Mol Hepatol. 2016;22(3):382-389. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0047

View: 12044 Download: 201 Web of Science: 18 Crossref: 19

Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment

Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi

Clin Mol Hepatol. 2016;22(3):350-358. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0019

View: 8937 Download: 138 Web of Science: 1 Crossref: 1

Case Report

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases

Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2016;22(2):286-291. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2015.0066

View: 10240 Download: 175 Web of Science: 11 Crossref: 13

Original Article

Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection

Hee Chul Nam, Hae Lim Lee, Hyun Yang, Myeong Jun Song

Clin Mol Hepatol. 2016;22(2):259-266. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0020

View: 9393 Download: 164 Web of Science: 8 Crossref: 7

The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy

Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon

Clin Mol Hepatol. 2016;22(2):241-249. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2015.0053

View: 9798 Download: 138 Web of Science: 4 Crossref: 4

Editorial

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?

Hyung Joon Yim

Clin Mol Hepatol. 2016;22(2):238-240. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0103

View: 8262 Download: 93 Web of Science: 1 Crossref: 1

Review

Prevention of Hepatitis B reactivation in the setting of immunosuppression

Venessa Pattullo

Clin Mol Hepatol. 2016;22(2):219-237. Published online June 13, 2016

DOI: https://doi.org/10.3350/cmh.2016.0024

View: 16747 Download: 652 Web of Science: 81 Crossref: 84

Case Report

Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis

Hye Young Jwa, Yoo-Kyung Cho, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong, Bong Soo Kim, Byoung-Wook Lee, Byung-Cheol Song

Clin Mol Hepatol. 2016;22(1):183-187. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.183

View: 11568 Download: 148 Web of Science: 4 Crossref: 4

Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C

Jong Wook Choi, June Sung Lee, Woo Hyun Paik, Tae Jun Song, Jung Wook Kim, Won Ki Bae, Kyung-Ah Kim, Jung Gon Kim

Clin Mol Hepatol. 2016;22(1):168-171. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.168

View: 9483 Download: 78 Web of Science: 5 Crossref: 7

Original Article

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B

Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park

Clin Mol Hepatol. 2016;22(1):152-159. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.152

View: 9412 Download: 94

Review

KASL clinical practice guidelines: management of hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2016;22(1):76-139. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.76

View: 26094 Download: 208 Web of Science: 64 Crossref: 54

KASL clinical practice guidelines: management of chronic hepatitis B

Clin Mol Hepatol. 2016;22(1):18-75. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.18

View: 24562 Download: 262 Web of Science: 152 Crossref: 134

Original Article

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea

Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2015;21(4):358-364. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.358

View: 8284 Download: 102 Web of Science: 12 Crossref: 11

Erectile dysfunction in patients with liver disease related to chronic hepatitis B

Min Kim, Seul Young Kim, Woo Sun Rou, Se Woong Hwang, Byung Seok Lee

Clin Mol Hepatol. 2015;21(4):352-357. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.352

View: 9316 Download: 124 Web of Science: 26 Crossref: 25

Comparison and analysis of the prevalence of hepatitis C virus infection by region in the Republic of Korea during 2005-2012

Hae-Sook Shon, Hwa Young Choi, Jang Rak Kim, So Yeon Ryu, Youn-Jae Lee, Myeong Jin Lee, Hyun Ju Min, Jun Lee, Yeong Jun Song, Moran Ki

Clin Mol Hepatol. 2015;21(3):249-256. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.249

View: 8765 Download: 83 Web of Science: 13 Crossref: 12

Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy

Jung Gil Park, Soo Young Park

Clin Mol Hepatol. 2015;21(3):242-248. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.242

View: 8084 Download: 84 Web of Science: 5 Crossref: 3

Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure

Jung Min Ha, Won Sohn, Ju Yeon Cho, Jeung Hui Pyo, Kyu Choi, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Chul Koh, Seung Woon Paik, Byung Chul Yoo, Yong-Han Paik

Clin Mol Hepatol. 2015;21(3):232-241. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.232

View: 7734 Download: 90 Web of Science: 7 Crossref: 7

Review

From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor

Jisu Li, Shuping Tong

Clin Mol Hepatol. 2015;21(3):193-199. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.193

View: 8706 Download: 199 Web of Science: 9 Crossref: 10

Original Article

Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients

Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim

Clin Mol Hepatol. 2015;21(2):131-140. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.131

View: 7784 Download: 84 Web of Science: 2 Crossref: 2

Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

Suh Yoon Yang, Hyun Woong Lee, Youn Jae Lee, Sung Jae Park, Ki Young Yoo, Hyung Joon Kim

Clin Mol Hepatol. 2015;21(2):125-130. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.125

View: 9180 Download: 64 Web of Science: 4 Crossref: 4

Editorial

Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?

Woo Sun Rou, Byung Seok Lee

Clin Mol Hepatol. 2015;21(2):122-124. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.122

View: 7907 Download: 103 Web of Science: 2

Original Article

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients

Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa

Clin Mol Hepatol. 2015;21(1):41-48. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.41

View: 8357 Download: 83 Web of Science: 14 Crossref: 11

The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B

In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim

Clin Mol Hepatol. 2015;21(1):32-40. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.32

View: 9330 Download: 88 Web of Science: 13 Crossref: 12

Viewed By 5676	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4932	MAFLD: How is it different from NAFLD?
Viewed By 4700	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3815	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3801	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Viral hepatitis